Global Perceptions on ERAS® in Pancreatoduodenectomy

Abstract

BackgroundUptake of ERAS® pathways for pancreatic surgery have been slow and impacted by low compliance.ObjectiveTo explore global awareness, perceptions and practice of ERAS® peri-pancreatoduodenectomy (PD).MethodsA structured, web-based survey (EPSILON) was administered through the ERAS® society and IHPBA membership.ResultsThe 140 respondents included predominantly males (86.4%), from Europe (45%), practicing surgery (95%) at academic/teaching hospitals (63.6%) over a period of 10–20 years (38.6%). Most respondents identified themselves as general surgeons (68.6%) with 40.7% reporting an annual PD volume of 20–50 cases, practicing post-PD clinical pathways (37.9%), with 31.4% of respondents auditing their outcomes annually. Reduced medical complications, cost and hospital length of stay, and improved patient satisfaction were perceived benefits of compliance to enhancing-recovery. Multidisciplinary co-ordination was considered the most important factor in the implementation and sustainability of peri-PD ERAS® pathways, while reluctance to change among health care practitioners, difficulties in data collection and audit, lack of administrative support, and recruitment of an ERAS® dedicated nurse were reported to be important barriers.ConclusionsThe EPSILON survey highlighted global clinician perceptions regarding the benefits of compliance to peri-PD ERAS®, the importance of individual components, perceived facilitators and barriers, to the implementation and sustainability of these pathways.